跳至主要内容
临床试验/NCT04162561
NCT04162561已完成不适用

Trying to Improve Quality of therApy in Patients With stabLe Coronary Artery dIsease According to Current Clinical GuideliNes (ALIGN)

National Research Center for Preventive Medicine1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年12月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
1
主要终点
Achievement of the target LDL-C and BP levels

研究概览

简要总结

The aim of this prospective cohort study is to assess the quality of therapy in patients with stable ischemic heart disease (IHD) who had never applied for specialized medical care for the last 3 years and try to accord their treatment with current clinical guidelines.

详细描述

The purpose of this study is to assess the quality of therapy in patients having come for the first time consultation to the specialized cardiology department of the scientific research centre within the PROFILE registry and to try to correct therapy according to current clinical guidelines paying particular attention to reaching target blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), glycosylated haemoglobin - HbA1c (in patients with diabetes mellitus) levels, improving exercise tolerance and quality of life.

The first visit (V0) is an inclusion in the study. During this visit, an attempt to correct or start (if it had not been started before) antiplatelet, hypolipidemic, antihypertensive and antianginal therapy will be made.

The second visit (V1) is planned for each patient three months after the first visit (V0). During the second visit number of patients who reached target levels of BP, LDL-C, frequency of angina attacks will be assessed. If necessary, correction of therapy will also be made.

The third visit (V2) is planned for each patient one year after the first visit (V0). During the third visit reaching target BP, LDL-C levels, frequency of angina attacks will be assessed. If necessary, therapy correction will be recommended.

The last visit - telephone contact with patients - is expected in 2 years after the first visit. During that visit it is planned to assess life status, complications and current medical treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with documented IHD having consequentially come for the first time for consultation to the specialized cardiology department of the scientific research center from December 31, 2017 to December 31,
  • Documented IHD:
  • Positive results of the angina questionnaire (typical angina)
  • Positive exercise electrocardiography or stress echocardiography, plus one of the following criteria:
  • ischemia documented by scintigraphy study
  • invasive coronary angiography data (stenosis of at least 75% in at least one main coronary artery)
  • previous coronary revascularization (percutaneous coronary intervention (PCI), coronary artery bypass graft surgery (CABG))
  • previous myocardial infarction
  • patients who had elective PCI or CABG

排除标准

  • Patients with acute IHD (less than 30 days since the last ischemic event with or without invasive procedures for the treatment of the event)
  • Patients' refuse to follow the study's graphic of doctors' visits

结局指标

主要结局

Achievement of the target LDL-C and BP levels

时间窗: 1 year

Target LDL-C levels - less than 1.8 mmol/l, target BP levels - less than 140/90 mmHg

Adherence to life-modifying treatment

时间窗: 1 year

The Adherence scale of the Russian National Society of evidence based pharmacotherapy modified for patients with coronary heart disease will be used to assess patients' adherence to treatment. The patients will be asked questions about taking prescribed medications as recommended by a doctor. The score system with the min value in the scale 0 and the max value 4 is used for the assessment of the results: 0 - adherent, 1-2 - partially adherent, 3 - partially non-adherent, 4 - non adherent.

次要结局

  • Unplanned hospitalization for cardiovascular diseases(2 years)
  • Myocardial revascularization(2 years)
  • all-cause mortality(2 years)
  • improvement of the functional class of angina in at least 1-grade level(1 year)
  • Myocardial Infarction(2 years)
  • Compliance to life-modifying treatment(1 year)
  • Stroke(2 years)

研究者

发起方
National Research Center for Preventive Medicine
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验